Peregrine Capital Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.93M | Sell |
88,695
-92,298
| -51% | -$9.29M | 0.27% | 101 |
|
|
2025
Q1 | $13.8M | Sell |
180,993
-12,486
| -6% | -$953K | 0.46% | 37 |
|
|
2024
Q4 | $13.4M | Buy |
193,479
+20,642
| +12% | +$1.43M | 0.4% | 48 |
|
|
2024
Q3 | $12.6M | Sell |
172,837
-7,095
| -4% | -$518K | 0.38% | 54 |
|
|
2024
Q2 | $12.1M | Sell |
179,932
-110,242
| -38% | -$7.39M | 0.35% | 58 |
|
|
2024
Q1 | $7.87M | Buy |
290,174
+86
| +0% | +$2.33K | 0.23% | 135 |
|
|
2023
Q4 | $8.99M | Sell |
290,088
-50,037
| -15% | -$1.55M | 0.27% | 102 |
|
|
2023
Q3 | $8.59M | Sell |
340,125
-21,396
| -6% | -$540K | 0.26% | 146 |
|
|
2023
Q2 | $7.63M | Sell |
361,521
-126
| -0% | -$2.66K | 0.21% | 201 |
|
|
2023
Q1 | $6.17M | Buy |
361,647
+10,678
| +3% | +$182K | 0.18% | 230 |
|
|
2022
Q4 | $7.01M | Sell |
350,969
-10,634
| -3% | -$212K | 0.22% | 208 |
|
|
2022
Q3 | $7.79M | Buy |
361,603
+31,915
| +10% | +$687K | 0.25% | 185 |
|
|
2022
Q2 | $6.5M | Sell |
329,688
-274
| -0.1% | -$5.4K | 0.2% | 227 |
|
|
2022
Q1 | $7.75M | Sell |
329,962
-23,665
| -7% | -$556K | 0.18% | 220 |
|
|
2021
Q4 | $9.63M | Buy |
353,627
+9,978
| +3% | +$272K | 0.19% | 207 |
|
|
2021
Q3 | $9.46M | Buy |
+343,649
| New | +$9.46M | 0.2% | 217 |
|